Search
BitMEX co-founder’s family office seeking $250M for private equity fund: Report
17.10.2025
The fund, to be run by Arthur Hayes and two associates, reportedly plans to use $40 million to $75 million for each acquisition of up to six crypto companies
Arthur Hayes’ Maelstrom Seeks $250M Private Equity Fund to Acquire Crypto Firms: Bloomberg
17.10.2025
Arthur Hayes’ Maelstrom family office is launching a private equity fund targeting infrastructure and analytics firms in crypto, aiming for $250 million in capital
Gamma Prime Hosted Tokenized Capital Summit in Singapore, Spotlighting Its Marketplace for Hedge Funds, VC, and Private Equity
13.10.2025
This content is provided by a sponsor. PRESS RELEASE. Gamma Prime, the marketplace for private investments specializing in hard-to-find non-correlated yield, hosted the Tokenized Capital Summit 2025 in Singapore on September 30, an event attended by over 2,500 attendees. With a speaker lineup that...
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens
Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
1.10.2025
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens